Placebo-adjusted mean weight loss of 16.3% (39 lbs) at 180 mg and 16.0% (37 lbs) at 240 mg at 44 weeks with no evidence of weight loss plateau in ...
Roche Holding AG expands Nvidia AI GPUs for drug R&D, tops peers with 3,500+ Blackwell chips, see value vs Eli Lilly and ...
Structure Therapeutics’ aleniglipron Phase 2 shows ~16% placebo-adjusted weight loss; a best-in-class oral GLP-1 with strong ...
Detailed price information for Americas Gold and Silver Corp (USAS-A) from The Globe and Mail including charting and trades.
Complementary biochemical and structural findings reveal molecular principles underlying substrate selectivity by a model hyaluronan synthase.
Argentometric titration of chloride is commonly used to quantify sodium in foodstuffs. This approach assumes that all sodium ...
Detailed price information for Structure Therapeutics Inc (GPCR-Q) from The Globe and Mail including charting and trades.
Evidence is provided suggesting that aggregate neural activity at an early stage of visual processing (V1) can directly contribute to perceptual decisions in humans.
Americas Gold and Silver is pleased to announce the discovery of seven new high-grade silver-copper-antimony veins and three new high-grade silver-lead veins at the Galena Complex. The Company is also ...
The AACE update to its 2026 algorithm for the management of type 2 diabetes includes a new section on diabetes classification ...
Five take-home messages for GPs on the recognition and management of attention deficit hyperactivity disorder (ADHD) in ...
Morning Overview on MSN
AI study of protein nanoribbons points to new design rules
Researchers at Pacific Northwest National Laboratory used artificial intelligence to analyze protein nanoribbons, pointing to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results